Expression of Nedd4Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4GMR.PU at 28[o]C does not affect eye development.
Expression of Nedd4Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4elav.PU does not affect climbing ability or lifespan.
Expression of Nedd4Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4elav.PLu does not produce ectopic midline crossing.
Expression of Nedd4Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4ptc-559.1 results in notching of the wing.
Over-expression of Nedd4 in all neurons has no effect on axon outgrowth.
Nedd4UAS.Tag:MYC, Scer\GAL4elav-C155 is an enhancer of abnormal neuroanatomy phenotype of Scer\GAL4elav-C155, commUAS.cWa
Scer\GAL4elav-C155/Nedd4UAS.Tag:MYC is an enhancer of abnormal neuroanatomy | dominant phenotype of robo15, sli[+]/sli1
Nedd4UAS.Tag:MYC, Scer\GAL4elav.PLu is a non-enhancer of abnormal neuroanatomy | embryonic stage 16 phenotype of Scer\GAL4elav.PLu, commUAS.Tag:MYC
Nedd4UAS.Tag:MYC/Scer\GAL4elav.PLu is a non-enhancer of abnormal neuroanatomy | embryonic stage 16 phenotype of robo11, sli2
Scer\GAL4insc-Mz1407/Nedd4UAS.Tag:MYC is a non-enhancer of abnormal neuroanatomy | embryonic stage 16 phenotype of robo11, sli2
Nedd4UAS.Tag:MYC, Scer\GAL4elav.PU is a suppressor of abnormal locomotor behavior phenotype of Hsap\SNCAUAS.cFa, Scer\GAL4elav.PU
Nedd4UAS.Tag:MYC, Scer\GAL4elav-C155 is an enhancer of larval anterior commissure phenotype of Scer\GAL4elav-C155, commUAS.cWa
Nedd4UAS.Tag:MYC, Scer\GAL4elav-C155 is an enhancer of larval posterior commissure phenotype of Scer\GAL4elav-C155, commUAS.cWa
Nedd4UAS.Tag:MYC, Scer\GAL4elav-C155 is an enhancer of larval ventral nerve cord phenotype of Scer\GAL4elav-C155, commUAS.cWa
Scer\GAL4elav-C155/Nedd4UAS.Tag:MYC is an enhancer of larval anterior commissure phenotype of robo15, sli[+]/sli1
Scer\GAL4elav-C155/Nedd4UAS.Tag:MYC is an enhancer of larval posterior commissure phenotype of robo15, sli[+]/sli1
Scer\GAL4elav-C155/Nedd4UAS.Tag:MYC is an enhancer of larval ventral nerve cord phenotype of robo15, sli[+]/sli1
Nedd4UAS.Tag:MYC/Scer\GAL4elav.PLu is a non-enhancer of larval longitudinal connective | embryonic stage 16 phenotype of robo11, sli2
Nedd4UAS.Tag:MYC/Scer\GAL4elav.PLu is a non-enhancer of commissure | embryonic stage 16 phenotype of robo11, sli2
Scer\GAL4insc-Mz1407/Nedd4UAS.Tag:MYC is a non-enhancer of larval longitudinal connective | embryonic stage 16 phenotype of robo11, sli2
Scer\GAL4insc-Mz1407/Nedd4UAS.Tag:MYC is a non-enhancer of commissure | embryonic stage 16 phenotype of robo11, sli2
Nedd4UAS.Tag:MYC, Scer\GAL4elav.PLu is a non-enhancer of larval longitudinal connective | embryonic stage 16 phenotype of Scer\GAL4elav.PLu, commUAS.Tag:MYC
Nedd4UAS.Tag:MYC, Scer\GAL4elav.PLu is a non-enhancer of commissure | embryonic stage 16 phenotype of Scer\GAL4elav.PLu, commUAS.Tag:MYC
Nedd4UAS.Tag:MYC, Scer\GAL4GMR.PU is a suppressor of eye | heat sensitive phenotype of Hsap\SNCAUAS.cFa, Scer\GAL4GMR.PU
Nedd4UAS.Tag:MYC/Scer\GAL4GMR.PU is a suppressor of dopaminergic neuron phenotype of Hsap\SNCAUAS.cFa, Scer\GAL4elav.PU
Expression of Nedd4Scer\UAS.T:Hsap\MYC does not enhance the aberrant midline crossing phenotype seen when commScer\UAS.T:Hsap\MYC is expressed under the control of Scer\GAL4elav.PLu in stage 16 embryos.
Expression of Nedd4Scer\UAS.T:Hsap\MYC under the control of either Scer\GAL4elav.PLu or Scer\GAL41407 does not enhance the midline crossing phenotype seen in transheterozygous sli2 robo1 stage 16 embryos.
In sli1/+,robo5/+ double heterozygote embryos the occasional axon crosses the midline. This phenotype is dramatically enhanced by Nedd4Scer\UAS.T:Hsap\MYC.
Co-expression of Nedd4Scer\UAS.T:Hsap\MYC suppresses the rough eye phenotype induced by expression of Hsap\SNCAScer\UAS.cFa in the developing eye under the control of Scer\GAL4GMR.PU.
Co-expression of Nedd4Scer\UAS.T:Hsap\MYC prevents the climbing deficit associated with neuronal Hsap\SNCAScer\UAS.cFa expression (both constructs under the control of Scer\GAL4elav.PU.
Co-expression of Nedd4Scer\UAS.T:Hsap\MYC prevents Hsap\SNCAScer\UAS.cFa-induced dopaminergic cell loss.